An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a...
Vous n'êtes pas connecté
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center (NYGC) and Memorial Sloan Kettering Cancer Center (MSK).
An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a...
Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at...
Eight aspiring scientists began building successful careers in research as they graduated from the Biomedical Research Training Program for Nationals...
A genetic test detecting brain cancer markers in cerebrospinal fluid reduces diagnostic time and eliminates the need for invasive biopsies....
Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...
Researchers at the University of Michigan Rogel Cancer Center have developed a 15-gene signature that helps classify clear cell kidney cancer patients...
Scientists at Weill Cornell Medicine have made a groundbreaking discovery about the immune system that could improve treatments for chronic...
A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024...